Kanyonyo, M R
Poupaert, Jacques
[UCL]
Lambert, Didier
[UCL]
An original ameltolide analogue 4-amino-(2-methyl-4-aminophenyl)benzamide, in which a second amino group has been introduced, was synthesized and evaluated for anticonvulsant activity. After intraperitoneal administration to mice, 4-amino-(2-methyl-4-aminophenyl)benzamide was found active in the maximal electroshock seizure test and against the tonic seizures elicited either by bicuculline or 3-mercaptopropionic acid. 4-amino-(2-methyl-4-aminophenyl)benzamide (4A-2M4A-PB) gave anti maximal electroshock seizures ED50 of 63 micromol/kg (15.4 mg/kg) and a TD50 of 676 micromol/kg (163 mg/kg), yielding a PI of 10.7; the potency is similar to that of the 4-amino-(2-methyl-3-aminophenyl)phthalimide (4A-2M3A-PP), superior to that of 4-amino-(2,6-dimethylphenyl)phthalimide (4A-2,6-DMPP), close to that of phenytoin and carbamazepine and inferior to that of ameltolide. 4A-2M4A-PB with an ED50 of 41[28-60] micromol/kg (9.9 mg/kg) is as active after oral administration to rats as carbamazepine, more active than ameltolide, 4-A-2M3A-PP and phenytoin and slightly less active than the 4A-2,6-DMPP. The introduction of a second amino group on the substituted phenyl ring does not affect drastically the anticonvulsant potency after intraperitoneal administration to mice; moreover, it seems to enhance the activity after oral administration. 4A-2M4A-PB is a good candidate both for further pharmacokinetic studies and for the study of the precise mechanism of action.
- Bailleux, Biomed. Pharmacother., 48, 95 (1994)
- Bailleux, Biomed. Pharmacother., 42, 1817 (1994)
- Bailleux, Epilepsia, 36, 559 (1995)
- Clark, J. Med. Chem., 27, 779 (1984)
- Clark, J. Med. Chem., 29, 1534 (1985)
- Clark, J. Med. Chem., 28, 1259 (1986)
- Clark, J. Med. Chem., 30, 1214 (1987)
- Clark, Epilepsia, 29, 198 (1990)
- Guelen, Rational anti-epileptic drug therapy, 1 (1978)
- Krall, Epilepsia, 19, 409 (1978)
- Lambert, Pharm. Sci., 1, 181 (1995)
- Leandcr, Neuropharmacology, 27, 623 (1988)
- Macdonald, Epilepsia, 36, S2 (1995)
- Meldrum, Epilepsia, 37, S4 (1996)
- Porter R. J., Cereghino J. J., Gladding G. D., Hessie B. j., Kupferberg H. J., Scoville B., White B. G., Antiepileptic Drug Development Program, 10.3949/ccjm.51.2.293
- Poupaert Jacques H., Hamoir Gaëtane, Barbeaux Philippe, Lambert Didier, Hénichart Jean-Pierre, Anticonvulsant Activity of Some N-Phenylphthalimide Derivatives in Rats and Mice, 10.1111/j.2042-7158.1995.tb05741.x
Bibliographic reference |
Kanyonyo, M R ; Poupaert, Jacques ; Lambert, Didier. Anticonvulsant profile of 4-amino-(2-methyl-4-aminophenyl)benzamide in mice and rats.. In: Pharmacology & toxicology, Vol. 82, no. 1, p. 47-50 (1998) |
Permanent URL |
http://hdl.handle.net/2078.1/24218 |